Clinical Trials Directory

Trials / Completed

CompletedNCT02350881

Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.

A Post-Market Observational Study to Evaluate Safety and Performance of Primus™ FGT Implant at a Minimum of 5 Years Follow-up

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Stryker Trauma and Extremities · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Foot silicone implants suffer from bad reputation on the market, due to poor results obtained with the first generations of implants. Allergies to silicone, infections due to silicone and implants breakage used to be common with previous generations of silicone implants. Publications relative to those implants showed that the survival rates after 5 years of follow-up were unsatisfactory. Since 1998, Tornier has been selling a new generation of silicone implants made of Ultrasil™. The use of this new material in its manufacturing process together with its innovative geometry, make the Primus™ FGT a much more resistant, anatomic and long lasting implant. The main objective of this study is to evaluate the clinical outcomes of the implantation of Primus™ FGT implant in great toe arthroplasty. The study will capture long term outcomes in terms of functional metrics from documented clinical data. Other objectives are to evaluate the outcomes in terms of radiological evaluation and of safety during all the follow-up.

Detailed description

This is an observational post-marketing surveillance study, performed by 1 (one) investigator in 1 (one) Italian site. * Preoperative and peroperative data were collected retrospectively. * Postoperative data (minimum 5 years follow-up or until implant revision) were collected prospectively.

Conditions

Interventions

TypeNameDescription
DEVICEPrimus FGTI (Flexible Great toe Implant)Great toe arthroplasty consists of replacing the first Meta-Tarso-Phalangeal (MTP1) joint by a two hinged prosthesis made of silicone : the Primus FGT implant (FGTI). The Primus is designed with an axially offset hinge to align with the anatomy of the MTP joint. This results in less implant stresses and improved toe function.

Timeline

Start date
2013-05-01
Primary completion
2014-06-01
Completion
2014-11-01
First posted
2015-01-30
Last updated
2016-10-31
Results posted
2016-10-31

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02350881. Inclusion in this directory is not an endorsement.